Lutonix 035 drug coated balloon percutaneous transluminal angioplasty catheter (Lutonix DCB)
Jump to navigation
Jump to search
Introduction
paclitaxel-coated angioplasty balloon catheter
Indications
- peripheral arterial disease
- FDA-approved for superficial femoral artery & popliteal artery occlusion[1]
Contraindications
- contraindicated in patients with hypersensitivity to paclitaxel
- apparent lack of benefit for women
More general terms
Additional terms
References
- ↑ 1.0 1.1 FDA News Release. October 10, 2014 FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418455.htm